Post-IPO Equity - Outlook Therapeutics - Feb 16, 2021 Funding Round Profile - Cointime

Bitcoin $92,991.08 -3.24%
Ethereum $3,304.90 -6.29%
BNB $614.70 -5.51%
Optimism $2.17 -10.11%
Arbitrum $0.86 -9.69%
Solana $228.23 -6.98%
Polygon $0.52 -11.23%
Cosmos $7.79 -6.55%
Avalanche $41.27 -5.41%

Bitcoin $92,991.08 -3.24%
Ethereum $3,304.90 -6.29%
BNB $614.70 -5.51%
Optimism $2.17 -10.11%
Arbitrum $0.86 -9.69%
Solana $228.23 -6.98%
Polygon $0.52 -11.23%
Cosmos $7.79 -6.55%
Avalanche $41.27 -5.41%

Outlook Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 42.60M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
May 26, 2020	Post-IPO Equity	$ 27.20M	Syntone Ventures	Detail
Jul 27, 2015	Series Unknown	$ 31M	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Nov 5, 2018	Post-IPO Equity	$ 20M	Biolexis	Detail
Jan 29, 2021	Post-IPO Equity	$ 35M		Detail
Sep 29, 2015	Series Unknown	0	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Feb 24, 2020	Post-IPO Equity	$ 10.20M		Detail
May 14, 2018	Post-IPO Equity	$ 15M	GMS Tenshi Holdings	Detail
May 13, 2016	IPO	$ 35M		Detail